The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 119:1092-1093, May 1963
doi: 10.1176/appi.ajp.119.11.1092
© 1963 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by KENNEDY, R. E.
* Articles by MILLER, J. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by KENNEDY, R. E.
* Articles by MILLER, J. J.

AMITRIPTYLINE-PERPHENAZINE IN THE TREATMENT OF SCHIZOPHRENIA

R. E. KENNEDY M.D., and J. J. MILLER M.D.1

1 Rollman Psychiatric Institute, Cincinnati, Ohio.

One-hundred and thirty-seven hospitalized schizophrenic patients received amitriptyline-perphenazine for periods seldom exceeding 90 days with a remission rate of about 86%. A possible rationale for the treatment is offered.






Get information about faster international access.

Privacy Policy

Copyright © 1963 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org